BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24689522)

  • 1. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
    Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
    J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
    Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
    J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report.
    Liu S; Tunkel R; Lachmann E; Nagler W
    Arch Phys Med Rehabil; 2000 Jun; 81(6):834-6. PubMed ID: 10857534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma first presenting as paraneoplastic cerebellar degeneration.
    Erez Y; Rojansky N; Shveiky D; Ben-Meir A; Benshushan A
    Gynecol Oncol; 2007 Jun; 105(3):826-7. PubMed ID: 17428523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation.
    Bradley WH; Dottino PR; Rahaman J
    Int J Gynecol Cancer; 2008; 18(6):1364-7. PubMed ID: 18217973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic cerebellar degeneration as the first manifestation of cancer.
    Lin JT; Lachmann E; Nagler W
    J Womens Health Gend Based Med; 2001 Jun; 10(5):495-502. PubMed ID: 11445049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration.
    Forgy AP; Ewing TL; Flaningam J
    Gynecol Oncol; 2001 Jan; 80(1):96-8. PubMed ID: 11136578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer: PCD and brain metastases.
    Stepanić V; Matković V; Corusić A; Barisić D; Buković D; Ilić-Forko J
    Coll Antropol; 2007 Jun; 31(2):633-6. PubMed ID: 17847951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report.
    Abdulaziz ATA; Yu XQ; Zhang L; Jiang XY; Zhou D; Li JM
    Medicine (Baltimore); 2018 Jun; 97(24):e10717. PubMed ID: 29901574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
    Saeed DB; Gupta L
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Yo positive and late-onset paraneoplastic cerebellar degeneration associated with ovarian carcinoma: A case report.
    Cui D; Xu L; Li WY; Qian WD
    Medicine (Baltimore); 2017 Aug; 96(32):e7362. PubMed ID: 28796031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
    Lehner MJ; Gheeya JS; Siddiqui BA; Tummala S
    J Neurooncol; 2021 Jul; 153(3):441-446. PubMed ID: 34076832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
    Key RG; Root JC
    Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis.
    Gracien R; Kordulla M; Ziemann U
    Mult Scler; 2011 Apr; 17(4):498-500. PubMed ID: 21148018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy].
    Tsuboguchi S; Yajima R; Higuchi Y; Ishikawa M; Kawachi I; Koyama Y; Nishizawa M
    Rinsho Shinkeigaku; 2016 Jul; 56(7):477-80. PubMed ID: 27356731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
    Le May M; Dent S
    Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.